{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/contraception-emergency/background-information/efficacy/","result":{"pageContext":{"chapter":{"id":"0f4766cd-a6cc-5421-9dae-55e1e6f95474","slug":"efficacy","fullItemName":"Efficacy","depth":2,"htmlHeader":"<!-- begin field b0a82244-a9a5-49bf-88b5-4cd9ca67f95b --><h2>How effective are the different methods of emergency contraception?</h2><!-- end field b0a82244-a9a5-49bf-88b5-4cd9ca67f95b -->","summary":"","htmlStringContent":"<!-- begin item 2f15be3c-f26d-4319-b849-6eee16911c58 --><!-- begin field 72a10df0-7a6e-44e7-9738-98e20a9f3b3c --><ul><li><strong>The copper intrauterine device (Cu-IUD)</strong> <strong>is the most effective method of emergency contraception (EC).</strong><ul><li>The overall pregnancy rate is less than 0.1%. </li><li>The effectiveness of the Cu-IUD is not known to be affected by weight/body mass index (BMI) or drug treatments. </li></ul></li><li><strong>Ulipristal acetate may be more effective than levonorgestrel and is licensed to be used up to 5 days (120 hours) after unprotected sexual intercourse (UPSI).</strong><br><ul><li>The overall pregnancy rate after administration of ulipristal acetate is about 1–2%. This means that about 1–2% of all women who take ulipristal acetate after UPSI will become pregnant, but it does not mean that a woman who has taken ulipristal acetate after UPSI just prior to ovulation has only a 1–2% chance of pregnancy.</li><li>Ulipristal acetate can delay ovulation even after the start of the luteinizing hormone (LH) surge, a time when levonorgestrel is no longer effective. However, it is unlikely to be effective if taken after ovulation.</li><li>The effectiveness of ulipristal acetate could be reduced if:<ul><li>The woman is taking a <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-emergency/management/management/#liver-enzyme-inducing-drugs\">liver enzyme-inducing drug</a>.</li><li>A progestogen was taken in the 5 days after taking ulipristal acetate, or in the 7 days prior to taking ulipristal acetate (theoretical risk).</li></ul></li><li>No significant reduction in effectiveness is observed with increasing time between UPSI and ulipristal acetate intake (up to 120 hours).</li></ul></li><li><strong>Levonorgestrel <strong>is licensed to be used up to</strong> 72 hours after UPSI.</strong> <br><ul><li>The overall pregnancy rate amongst women taking levonorgestrel within 72 hours of UPSI to be about 0.6–2.6%. </li><li>In contrast to ulipristal acetate, levonorgestrel effectively delays ovulation when taken before the beginning of the LH surge, but not thereafter. This has implications for choice of oral EC when a woman is likely to be close to ovulation.</li><li>Levonorgestrel is unlikely to be effective if taken after ovulation.</li><li>The effectiveness of levonorgestrel could be reduced if the woman:<ul><li>Has BMI greater than 26 kg/m<sup>2 </sup>or weight greater than 70 kg. </li><li>Is taking a <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-emergency/management/management/#liver-enzyme-inducing-drugs\">liver enzyme-inducing drug</a>.</li></ul></li><li>Levonorgestrel is ineffective if taken more than 96 hours after UPSI.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-emergency/references/\">ABPI, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-emergency/references/\">ABPI, 2020</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-emergency/references/\">FSRH, 2020</a>]</p><!-- end field 72a10df0-7a6e-44e7-9738-98e20a9f3b3c --><!-- end item 2f15be3c-f26d-4319-b849-6eee16911c58 -->","topic":{"id":"34b55d4c-9cac-525d-86dc-99cef03c6806","topicId":"9cd56dfa-04c2-427b-b19d-f31d21101fcf","topicName":"Contraception - emergency","slug":"contraception-emergency","lastRevised":"February 2021","chapters":[{"id":"1b6cbbf8-da0c-5fb6-b093-e2d3c5572c11","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"2989e386-a7c8-5dfe-be90-e6943a9877ef","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"74dc3e64-bbad-528b-906a-a8601cc2ba5d","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"30374e39-19e0-54bd-bc62-8fda710d4001","slug":"changes","fullItemName":"Changes"},{"id":"9ff3bda9-0586-5b0e-b7ee-71fca4a46217","slug":"update","fullItemName":"Update"}]},{"id":"70ba6931-c855-5dfc-9648-c4e96af62c28","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"d140f826-870b-5b1d-930f-fae9d8becf7d","slug":"goals","fullItemName":"Goals"},{"id":"43508403-5950-574a-a205-d99d46e212d3","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a459bdcb-4c8b-5ec7-a58a-b1388d668be2","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"954d04db-f8fb-5cf7-b20d-fabe1ea4d9a5","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"c8b415dd-c103-5034-8775-8da2e419a7d9","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - options for local implementation"},{"id":"70825b99-5fd2-536c-8f45-3be301c38418","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"55f26b80-2a05-5f41-9391-83a93ef8e35f","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"44b97a41-f563-505c-bf6b-3a68428f5de6","slug":"definition","fullItemName":"Definition"},{"id":"66b12635-36ac-5e3e-8b27-96c86116aaf5","slug":"available-methods","fullItemName":"Available methods"},{"id":"d5554b35-952b-5ff7-9775-99ae976c98ea","slug":"mode-of-action","fullItemName":"Mode of action"},{"id":"0f4766cd-a6cc-5421-9dae-55e1e6f95474","slug":"efficacy","fullItemName":"Efficacy"},{"id":"8becba3f-f7c7-595c-bf5d-c478d64406a9","slug":"advantages-disadvantages","fullItemName":"Advantages and disadvantages"},{"id":"95c6136e-5abb-59f4-9e69-a300ffa8ae5b","slug":"where-to-obtain-emergency-contraception","fullItemName":"Where to obtain emergency contraception"}]},{"id":"ad8d32de-a804-5db6-a703-31de5d377c53","fullItemName":"Management","slug":"management","subChapters":[{"id":"2725764e-0d81-5172-adbc-548550b28479","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"8474bad2-5937-5c2f-b8d5-e7456df9b422","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"ebabd585-93a7-5f5d-ab3b-4cd5bf562f0a","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"f89aa991-bafc-54c0-bbaa-527b5e4c5be0","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"cc96bca5-24a4-5e19-a298-02b088b18c3a","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"dea5d633-048c-5093-acf5-566601be374b","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"dacfc7ec-129c-5684-8b24-1317952f7877","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"51674ea1-fc7f-565b-a479-c23d1e0cefac","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"32694ff7-74d1-5732-bc83-7d191dc81196","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"55f26b80-2a05-5f41-9391-83a93ef8e35f","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}